Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese"

Pfizer

Status: Completed

Conditions: Small for Gestational Age (SGA)

Treatments: Drug: Somatropin

Study type: Observational

Funder types: Industry

Identifiers

NCT01897766

A6281314

Details and patient eligibility

About

The objective of this surveillance is to collect Safety and Effectiveness information for Long term Use of Somatropin for Patients with a Small for Gestational Age (SGA).

Full description

All the patients whom an investigator prescribes Genotropin should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.

Enrollment: 482 patients

Sex: All

Ages: 2 to 20 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A patient who was administered Somatropin (Genotropin).

Exclusion criteria

• N/A.

Trial design

482 participants in 1 patient group

Somatropin

Description:

Patients administered Somatropin.

Treatment:

Drug: Somatropin